Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)

Trial Profile

Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2017

At a glance

  • Drugs Fluticasone propionate (Primary) ; Omalizumab (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms PROSE
  • Most Recent Events

    • 01 Sep 2017 Results (n=92) of patients from two trial centers were published in the Journal of Allergy and Clinical Immunology
    • 13 Jun 2017 Results published in the American Journal of Respiratory and Critical Care Medicine
    • 24 May 2017 Results of association of microbiota existence and disease features presented at the 113th International Conference of the American Thoracic Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top